Your current location is:{Current column} >>Text
Trump aides contact Google, Meta, Snap over online drug sales, The Information reports By Reuters
{Current column}784People have watched
Introduction(Reuters) -President-elect Donald Trump's transition team has invited five major tech companies, inc ...
(Reuters) -President-elect Donald Trump's transition team has invited five major tech companies,hycm Industrial Bank foreign exchange official website including Google (NASDAQ:), Microsoft (NASDAQ:) and Meta Platforms (NASDAQ:) to a meeting in mid-December about dealing with online sales of drugs, The Information reported on Sunday.
A representative for Jim Carroll, the drug czar during Trump's first term, and Trump's transition team emailed staffers from the three tech giants on Thursday, as well as those from Snap and TikTok, to invite them to a call, the report added, citing a person with direct knowledge of the correspondence.

The transition officials want to hear from the companies about their priorities and any barriers to addressing issues around the sales of drugs online, the person told the Information.
Google, Microsoft, Meta, Snap, TikTok and the Trump transition team did not immediately respond to a Reuters' request for comment.
Trump has vowed to get Mexico to do more to stop the flow of fentanyl to the U.S., which has killed hundreds of thousands of Americans and threatened to impose steep tariffs on goods from Mexico and Canada unless those countries curb fentanyl trafficking and illegal migration.
In November, Trump also said in a post on Truth Social that he "will be working on a large scale United States Advertising Campaign, explaining how bad fentanyl is for people to use."

In March, The Wall Street Journal reported that U.S. prosecutors were investigating Meta's role and whether it profited from the sale and distribution of drugs on Facebook and Instagram.
In January, eBay (NASDAQ:) agreed to pay $59 million and upgrade compliance measures to resolve U.S. Department of Justice allegations that it didn't do enough to stop criminals from buying devices for making counterfeit drugs, including pills laced with fentanyl.
Statement: The content of this article does not represent the views of FTI website. The content is for reference only and does not constitute investment suggestions. Investment is risky, so you should be careful in your choice! If it involves content, copyright and other issues, please contact us and we will make adjustments at the first time!
Tags:
Related articles
U.S. Supreme Court to examine whistleblower claims against financial firms in UBS case By Reuters
{Current column}By Daniel Wiessner(Reuters) -The U.S. Supreme Court on Monday agreed to examine how difficult it sho ...
Read moreHow to navigate the Fed's pre
{Current column}-- The Federal Reserve is due to unveil its latest interest rate decision on Nov. 7, although offici ...
Read moreBoeing sells small defense surveillance unit to Thales By Reuters
{Current column}(Reuters) -Boeing closed a deal this month to sell a small defense subsidiary that makes surveillanc ...
Read more
Popular Articles
- Air Canada pilots end 10
- China stock market: 5 questions ahead of the key NPC session By
- PayPal forecasts Q4 revenue below estimates as profit push puts growth behind By Reuters
- Bitcoin price today: flounders around $67k amid weak sentiment, altcoins losses By
- Dollar bounces as expectations of Fed rate hike climb By Reuters
- Election night guide for investors: Here's what to watch By
Latest articles
-
Debt limit progress, weak Chinese data
-
Millions of Cubans still without power as crisis deepens By Reuters
-
What policy outcomes are likely regardless of the US election results? By
-
Oil slips nearly $4 a barrel after Israel shows restraint in strikes on Iran By Reuters
-
Pfizer pledge for more equal access to RSV shot faces hurdles By Reuters
-
Professional Trading Regulation Query & Financial Platform Regulation Query